Tracking eye Cancer's return: a search for early warning signs
NCT ID NCT04424719
Summary
This study aims to find better ways to monitor patients with high-risk uveal melanoma (a type of eye cancer) for signs that the cancer has spread to the liver. Researchers will follow 700 patients for up to 10 years, collecting regular MRI scans and blood samples to look for biological markers that signal a relapse. The goal is to create a personalized follow-up schedule based on each patient's specific risk, allowing for earlier detection and treatment if the cancer returns.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Curie
RECRUITINGParis, 75005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.